nach oben

Erschienen in:

01.05.2012 | Clinical study

A study conducted in India showed that sublingual immunotherapy is safe during pregnancy

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

A study conducted in India showed that sublingual immunotherapy is safe during pregnancy even when initiated for the first time. A total of 155 patients received sublingual immunotherapy with either house dust mite (Dermatophagoides farinae) or a mixture of ≤ 5 allergens during 185 pregnancies - of these patients, 24 had received sublingual immunotherapy for the first time during their pregnancy. After 6 years of follow-up, the researchers reported a lower incidence of pregnancy complications, compared with both control groups and existing data for the general population. …

Shaikh WA, Shaikh SW.A prospective study on the safety of sublingual immunotherapy in pregnancy. Allergy: [3 pages], 5 Apr 2012. Available from: URL: http://dx.doi.org/10.1111/j.1398-9995.2012.02815.x

Titel: A study conducted in India showed that sublingual immunotherapy is safe during pregnancy
Publikationsdatum: 01.05.2012
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.2165/00128415-201214020-00009

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

A study conducted in India showed that sublingual immunotherapy is safe during pregnancy

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Pantoprazole

Etoposide/methotrexate/vincristine

Paracetamol

Cyclophosphamide/doxorubicin

Codeine/dextromethorphan/ephedrine abuse

Amiodarone